|
US8114414B2
(en)
*
|
1994-11-08 |
2012-02-14 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical cancer
|
|
US8956621B2
(en)
|
1994-11-08 |
2015-02-17 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical dysplasia
|
|
US7820180B2
(en)
*
|
2004-09-24 |
2010-10-26 |
The Trustees Of The University Of Pennsylvania |
Listeria-based and LLO-based vaccines
|
|
US8791237B2
(en)
*
|
1994-11-08 |
2014-07-29 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of non-hodgkins lymphoma
|
|
US7794729B2
(en)
*
|
1994-11-08 |
2010-09-14 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for immunotherapy of cancer
|
|
US6977074B2
(en)
*
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
US20030138808A1
(en)
*
|
1998-02-19 |
2003-07-24 |
Simard John J.L. |
Expression vectors encoding epitopes of target-associated antigens
|
|
US20030176663A1
(en)
*
|
1998-05-11 |
2003-09-18 |
Eidgenossische Technische Hochscule |
Specific binding molecules for scintigraphy
|
|
EP1259548A1
(en)
*
|
2000-02-24 |
2002-11-27 |
Eidgenössische Technische Hochschule Zürich |
Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
|
|
US9012141B2
(en)
*
|
2000-03-27 |
2015-04-21 |
Advaxis, Inc. |
Compositions and methods comprising KLK3 of FOLH1 antigen
|
|
JP2004500405A
(ja)
*
|
2000-03-29 |
2004-01-08 |
ザ トラスティーズ オブ ザ ユニバーシティー オブ ペンシルヴァニア |
抗原の免疫原性を増強するための組成物および方法
|
|
US20030215425A1
(en)
*
|
2001-12-07 |
2003-11-20 |
Simard John J. L. |
Epitope synchronization in antigen presenting cells
|
|
US20020197700A1
(en)
*
|
2000-09-07 |
2002-12-26 |
Schering Ag |
Receptor of the EDb-fibronectin domains
|
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
|
US7700344B2
(en)
*
|
2001-03-26 |
2010-04-20 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
WO2003008537A2
(en)
*
|
2001-04-06 |
2003-01-30 |
Mannkind Corporation |
Epitope sequences
|
|
WO2003034903A2
(en)
*
|
2001-10-23 |
2003-05-01 |
Psma Development Company, L.L.C. |
Psma antibodies and protein multimers
|
|
US20050215472A1
(en)
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
MXPA04005382A
(es)
*
|
2001-11-07 |
2005-02-24 |
Mannkind Corp |
Vectores de expresion que codifican epitopes de antigenos asociados al objetivo y metodos para su diseno.
|
|
WO2003068800A2
(en)
*
|
2002-02-13 |
2003-08-21 |
Ludwig Institute For Cancer Research |
Isolated peptides which bind to hla molecules and uses thereof
|
|
US20030228308A1
(en)
*
|
2002-06-05 |
2003-12-11 |
Yi Zhang |
Isolated peptides which bind to HLA-Cw6 molecules and uses thereof
|
|
EP1545610A4
(en)
*
|
2002-09-06 |
2006-11-08 |
Mannkind Corp |
EPITOPE SEQUENCES
|
|
CA2514419A1
(en)
*
|
2003-01-28 |
2004-08-12 |
Proscan Rx Pharma Inc. |
Prostate cancer diagnosis and treatment
|
|
US7178491B2
(en)
*
|
2003-06-05 |
2007-02-20 |
Caterpillar Inc |
Control system and method for engine valve actuator
|
|
GB0313132D0
(en)
*
|
2003-06-06 |
2003-07-09 |
Ich Productions Ltd |
Peptide ligands
|
|
US20050118186A1
(en)
*
|
2003-06-17 |
2005-06-02 |
Chih-Sheng Chiang |
Combinations of tumor-associated antigens in compositions for various types of cancers
|
|
JP5127224B2
(ja)
*
|
2003-06-17 |
2013-01-23 |
マンカインド コーポレイション |
予防又は治療目的のためのｍｈｃクラスｉ拘束性エピトープに対する免疫応答を誘発し、増強し、維持する方法
|
|
ATE496129T1
(de)
|
2003-07-22 |
2011-02-15 |
Ludwig Inst Cancer Res |
Von hla-klasse-ii-molekülen präsentierte ssx-2- peptide
|
|
ES2605443T3
(es)
|
2003-11-06 |
2017-03-14 |
Seattle Genetics, Inc. |
Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
|
|
NZ551180A
(en)
|
2004-06-01 |
2009-10-30 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
KR20070056042A
(ko)
*
|
2004-06-17 |
2007-05-31 |
맨카인드 코포레이션 |
에피토프 유사체
|
|
US20060159689A1
(en)
*
|
2004-06-17 |
2006-07-20 |
Chih-Sheng Chiang |
Combinations of tumor-associated antigens in diagnostics for various types of cancers
|
|
US20050287068A1
(en)
*
|
2004-06-17 |
2005-12-29 |
Bot Adrian I |
Efficacy of active immunotherapy by integrating diagnostic with therapeutic methods
|
|
US20060008468A1
(en)
*
|
2004-06-17 |
2006-01-12 |
Chih-Sheng Chiang |
Combinations of tumor-associated antigens in diagnostics for various types of cancers
|
|
US7858743B2
(en)
|
2004-09-09 |
2010-12-28 |
Ludwig Institute For Cancer Research |
SSX-4 peptides presented by HLA class II molecules
|
|
TR201808537T4
(tr)
|
2004-09-23 |
2018-07-23 |
Genentech Inc |
Sistein değiştirilmiş antikorlar ve konjugatlar.
|
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
|
EP1838342A2
(en)
*
|
2004-12-29 |
2007-10-03 |
Mannkind Corporation |
Methods to bypass cd+4 cells in the induction of an immune response
|
|
AU2005321898B2
(en)
|
2004-12-29 |
2012-07-19 |
Mannkind Corporation |
Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
|
|
CA2592922A1
(en)
|
2004-12-29 |
2006-07-06 |
Mannkind Corporation |
Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
|
|
WO2006071989A2
(en)
*
|
2004-12-29 |
2006-07-06 |
Mannkind Corporation |
Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
|
|
WO2006076678A2
(en)
*
|
2005-01-13 |
2006-07-20 |
The Johns Hopkins University |
Prostate stem cell antigen vaccines and uses thereof
|
|
EP2385059A3
(en)
*
|
2005-06-17 |
2012-02-15 |
Mannkind Corporation |
Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
|
|
NZ587601A
(en)
|
2005-06-17 |
2012-05-25 |
Mannkind Corp |
Multivalent Entrain-and-Amplify Immunotherapeutics for Carcinoma
|
|
US7511118B2
(en)
|
2005-06-17 |
2009-03-31 |
Mannkind Corporation |
PSMA peptide analogues
|
|
US20100184699A1
(en)
*
|
2005-06-29 |
2010-07-22 |
Kyogo Itoh |
Peptide Derived From Prostate-Related Protein As Cancer Vaccine Candidate For Prostate Cancer Patient Who Is Positive For Hla-A3 Super-Type Allele Molecule
|
|
ATE509033T1
(de)
|
2006-03-20 |
2011-05-15 |
Univ California |
Manipulierte anti-prostatastammzellenantigen (psca)-antikörper für krebs-targeting
|
|
EP2046344A2
(en)
*
|
2006-07-14 |
2009-04-15 |
MannKind Corporation |
Methods to elicit, enhance and sustain immune responses against mhc class-i restricted epitopes, for prophylactic or therapeutic purposes
|
|
CN101657213B
(zh)
*
|
2007-02-15 |
2014-02-26 |
曼康公司 |
用于增强t细胞应答的方法
|
|
EP3533461A3
(en)
|
2007-03-26 |
2019-12-18 |
Academisch Ziekenhuis Leiden h.o.d.n. LUMC |
Prame derived peptides and immunogenic compositions comprising these
|
|
EP2152890A1
(en)
*
|
2007-05-23 |
2010-02-17 |
MannKind Corporation |
Multicistronic vectors and methods for their design
|
|
ES2725450T3
(es)
|
2007-07-02 |
2019-09-24 |
Etubics Corp |
Métodos y composiciones para la producción de un vector adenoviral para su uso en vacunaciones múltiples
|
|
US8940298B2
(en)
|
2007-09-04 |
2015-01-27 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
|
|
CA2710061C
(en)
*
|
2007-12-19 |
2022-07-12 |
Rhovac Aps |
Rhoc-based immunotherapy
|
|
US8253725B2
(en)
*
|
2007-12-28 |
2012-08-28 |
St. Jude Medical, Atrial Fibrillation Division, Inc. |
Method and system for generating surface models of geometric structures
|
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
|
JP5757863B2
(ja)
|
2008-05-19 |
2015-08-05 |
アドバクシス インコーポレイテッド |
異種抗原のための二重送達システム
|
|
US10024868B2
(en)
*
|
2009-06-09 |
2018-07-17 |
Vaxon Biotech |
Identification, optimization and use of shared HLA-B*0702 epitopes for immunotherapy
|
|
AU2010292172A1
(en)
|
2009-09-09 |
2012-05-03 |
Centrose, Llc |
Extracellular targeted drug conjugates
|
|
EP2490713A2
(en)
|
2009-10-23 |
2012-08-29 |
MannKind Corporation |
Cancer immunotherapy and method of treatment
|
|
US10016617B2
(en)
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
|
CA2781248A1
(en)
*
|
2009-11-18 |
2011-05-26 |
Mannkind Corporation |
Monoclonal antibodies and diagnostic uses thereof
|
|
WO2011070440A2
(en)
|
2009-12-10 |
2011-06-16 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
|
SE535982C2
(sv)
*
|
2009-12-15 |
2013-03-19 |
Theravac Pharmaceuticals Ab |
Ett nytt vaccin som angriper tumörkärl som ett effektivt redskap i tumörterapi
|
|
EP2356998A1
(en)
*
|
2010-02-17 |
2011-08-17 |
Université de Liège |
A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (PRL)-growth hormone (GH) - placental lactogen (PL)-family protein
|
|
PT2528625E
(pt)
|
2010-04-15 |
2013-10-17 |
Spirogen Sarl |
Pirrolobenzodiazepinas e conjugados das mesmas
|
|
CA3220104A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
|
CN107412756A
(zh)
|
2010-10-01 |
2017-12-01 |
宾夕法尼亚大学理事会 |
李斯特菌疫苗载体用于在寄生虫感染的个体中扭转免疫无应答的用途
|
|
EP2640727B1
(en)
|
2010-11-17 |
2015-05-13 |
Genentech, Inc. |
Alaninyl maytansinol antibody conjugates
|
|
CA2829960A1
(en)
|
2011-03-11 |
2012-09-20 |
John Rothman |
Listeria-based adjuvants
|
|
EP2707723B1
(en)
|
2011-05-12 |
2016-02-10 |
Genentech, Inc. |
Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature pepides
|
|
GB201114919D0
(en)
*
|
2011-08-30 |
2011-10-12 |
Glaxosmithkline Biolog Sa |
Method
|
|
JP6104257B2
(ja)
|
2011-10-14 |
2017-03-29 |
メドイミューン・リミテッドMedImmune Limited |
ピロロベンゾジアゼピンおよびそのコンジュゲート
|
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
|
WO2013151664A1
(en)
*
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
BR112014022662A2
(pt)
|
2012-03-12 |
2017-10-03 |
Advaxis Inc |
Inibição da função de célula supressora seguindo tratamento de vacina de listeria
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
ES2835200T3
(es)
|
2012-05-22 |
2021-06-22 |
Us Health |
Uso médico de células que comprenden receptores de células T anti-NY-ESO-1
|
|
WO2013180200A1
(ja)
*
|
2012-05-30 |
2013-12-05 |
中外製薬株式会社 |
標的組織特異的抗原結合分子
|
|
US9605276B2
(en)
|
2012-08-24 |
2017-03-28 |
Etubics Corporation |
Replication defective adenovirus vector in vaccination
|
|
PT2906253T
(pt)
|
2012-10-12 |
2018-11-05 |
Medimmune Ltd |
Conjugados de anticorpo anti-psma de pirrolobenzodiazepina
|
|
KR101995620B1
(ko)
|
2012-10-12 |
2019-07-03 |
에이디씨 테라퓨틱스 에스에이 |
피롤로벤조디아제핀-항체 컨주게이트
|
|
EP2906297B1
(en)
|
2012-10-12 |
2017-12-06 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
DK2839860T3
(da)
|
2012-10-12 |
2019-06-17 |
Medimmune Ltd |
Pyrrolobenzodiazepiner og konjugater deraf
|
|
DK2906298T3
(en)
|
2012-10-12 |
2018-12-17 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
WO2014057114A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-anti-psma antibody conjugates
|
|
BR112015008238A2
(pt)
|
2012-10-12 |
2017-11-28 |
Adc Therapeutics Sarl |
conjugados de pirrolbenzodiazepina-anticorpo anti-cd22
|
|
US9567340B2
(en)
|
2012-12-21 |
2017-02-14 |
Medimmune Limited |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
|
AU2013366493B2
(en)
|
2012-12-21 |
2017-08-24 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
RU2019107976A
(ru)
|
2013-02-21 |
2019-08-23 |
Тёрнстоун Лимитед Партнершип |
Композиция вакцины
|
|
KR102066318B1
(ko)
|
2013-03-13 |
2020-01-14 |
메디뮨 리미티드 |
피롤로벤조디아제핀 및 그의 컨쥬게이트
|
|
MX363787B
(es)
|
2013-03-13 |
2019-04-03 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de los mismos.
|
|
ES2687439T3
(es)
|
2013-03-13 |
2018-10-25 |
Medimmune Limited |
Pirrolobenzodiazepinas y conjugados de las mismas
|
|
CN105555756B
(zh)
|
2013-06-28 |
2018-12-07 |
奥克兰联合服务有限公司 |
氨基酸缀合物和肽缀合物及缀合方法
|
|
MX369925B
(es)
*
|
2013-07-05 |
2019-11-25 |
Arla Foods Amba |
Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria.
|
|
BR112016002829A2
(pt)
|
2013-08-12 |
2017-09-19 |
Genentech Inc |
Composto e processo para preparar o composto de conjugado anticorpo-¿droga, composição farmacêutica, método de tratamento do câncer, kit para o tratamento do câncer, intermediário ligante¿-droga, porção e composto de porção droga de dímero cbi
|
|
US10010624B2
(en)
|
2013-10-11 |
2018-07-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2015052534A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
WO2015052535A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
TWI702316B
(zh)
|
2013-12-04 |
2020-08-21 |
日商中外製藥股份有限公司 |
因應化合物濃度使抗原結合能力變化的抗原結合分子及其資料庫
|
|
UA118113C2
(uk)
|
2013-12-16 |
2018-11-26 |
Дженентек, Інк. |
Пептидоміметичні сполуки та їх кон'югати антитіла з лікарським засобом
|
|
JP6980384B2
(ja)
|
2013-12-16 |
2021-12-15 |
ジェネンテック， インコーポレイテッド |
１−（クロロメチル）−２，３−ジヒドロ−１ｈ−ベンゾ［ｅ］インドール二量体抗体−薬物コンジュゲート化合物、並びに使用及び処置の方法
|
|
BR112016012410A2
(pt)
|
2013-12-16 |
2017-09-26 |
Genentech Inc |
conjugado de droga e anticorpo, composto conjugado de droga e anticorpo, composto não-peptídico, método de tratamento de doenças em seres humanos e composição farmacêutica
|
|
KR101503341B1
(ko)
*
|
2014-03-12 |
2015-03-18 |
국립암센터 |
자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법
|
|
EP3193940A1
(en)
|
2014-09-10 |
2017-07-26 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US10149913B2
(en)
|
2014-09-12 |
2018-12-11 |
Genentech, Inc. |
Anthracycline disulfide intermediates, antibody-drug conjugates and methods
|
|
JP2017531620A
(ja)
|
2014-09-12 |
2017-10-26 |
ジェネンテック， インコーポレイテッド |
システイン操作抗体及びコンジュゲート
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
JP2017533887A
(ja)
|
2014-09-17 |
2017-11-16 |
ジェネンテック， インコーポレイテッド |
ピロロベンゾジアゼピン類及びその抗体ジスルフィドコンジュゲート
|
|
CN107148285B
(zh)
|
2014-11-25 |
2022-01-04 |
Adc治疗股份有限公司 |
吡咯并苯并二氮杂䓬-抗体缀合物
|
|
CA2969689A1
(en)
|
2014-12-03 |
2016-06-09 |
Genentech, Inc. |
Quaternary amine compounds and antibody-drug conjugates thereof
|
|
CA2971677A1
(en)
|
2014-12-23 |
2016-06-30 |
Margaret Anne Brimble |
Amino acid and peptide conjugates and uses thereof
|
|
AU2016205215B2
(en)
|
2015-01-09 |
2021-03-11 |
Etubics Corporation |
Methods and compositions for combination immunotherapy
|
|
US10695417B2
(en)
|
2015-01-09 |
2020-06-30 |
Etubics Corporation |
Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
US11149087B2
(en)
|
2015-04-20 |
2021-10-19 |
Etubics Corporation |
Methods and compositions for combination immunotherapy
|
|
CR20180243A
(es)
|
2015-10-02 |
2018-07-31 |
Genentech Inc |
Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso
|
|
MA43354A
(fr)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
Conjugués médicamenteux à pont disulfure encombré
|
|
JP6852065B2
(ja)
|
2015-10-20 |
2021-03-31 |
ジェネンテック， インコーポレイテッド |
カリケアマイシン−抗体−薬物コンジュゲート及び使用方法
|
|
CN106610423A
(zh)
*
|
2015-10-26 |
2017-05-03 |
复旦大学 |
评价疫苗疗效的细胞免疫学检测试剂盒及其储存方法
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
TW201735952A
(zh)
|
2016-02-26 |
2017-10-16 |
瑪格蕾特 安 布萊博 |
胺基酸及肽共軛物以及共軛過程
|
|
CN108700598A
(zh)
|
2016-03-25 |
2018-10-23 |
豪夫迈·罗氏有限公司 |
多路总抗体和抗体缀合的药物量化测定法
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
CN109152843A
(zh)
|
2016-05-20 |
2019-01-04 |
豪夫迈·罗氏有限公司 |
Protac抗体缀合物及其使用方法
|
|
AU2017271136A1
(en)
*
|
2016-05-23 |
2019-01-03 |
The Council Of The Queensland Institute Of Medical Research |
CMV epitopes
|
|
CN109313200B
(zh)
|
2016-05-27 |
2022-10-04 |
豪夫迈·罗氏有限公司 |
用于表征位点特异性抗体-药物缀合物的生物分析性方法
|
|
JP7043425B2
(ja)
|
2016-06-06 |
2022-03-29 |
ジェネンテック， インコーポレイテッド |
シルベストロール抗体－薬物コンジュゲート及び使用方法
|
|
WO2018031662A1
(en)
|
2016-08-11 |
2018-02-15 |
Genentech, Inc. |
Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
|
|
JP7050770B2
(ja)
|
2016-10-05 |
2022-04-08 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
抗体薬物コンジュゲートの調製方法
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
RS61795B1
(sr)
|
2017-02-08 |
2021-06-30 |
Adc Therapeutics Sa |
Konjugati pirolobenzodiazepin antitela
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
SMT202200490T1
(it)
|
2017-04-18 |
2023-01-13 |
Medimmune Ltd |
Coniugati di pirrolobenzodiazepina
|
|
WO2018193102A1
(en)
|
2017-04-20 |
2018-10-25 |
Adc Therapeutics Sa |
Combination therapy with an anti-axl antibody-drug conjugate
|
|
KR102442736B1
(ko)
|
2017-06-14 |
2022-09-16 |
에이디씨 테라퓨틱스 에스에이 |
항-cd19 adc의 투여를 위한 투약량 체제
|
|
KR20200026898A
(ko)
|
2017-07-07 |
2020-03-11 |
이매틱스 바이오테크놀로지스 게엠베하 |
Nsclc, sclc 등 폐암 및 기타 암에 대한 면역요법에서의 사용을 위한 신규 펩티드 및 펩티드의 조합
|
|
CN108503689B
(zh)
*
|
2017-07-10 |
2019-12-31 |
昆明医科大学第一附属医院 |
一种抗血小板聚集的多肽km6
|
|
SI3668874T1
(sl)
|
2017-08-18 |
2022-04-29 |
Medimmune Limited |
Pirolobenzodiazepinski konjugati
|
|
ES3075078T3
(es)
|
2017-09-20 |
2026-07-27 |
Ph Pharma Co Ltd |
Análogos de tailanstatina
|
|
EP3689903A4
(en)
*
|
2017-09-30 |
2022-01-12 |
Hefei Lifeon Pharmaceutical Co. Ltd. |
BINDING OF PROTEIN TO FIBRONECTIN B DOMAIN
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
CN110343167B
(zh)
*
|
2018-04-03 |
2022-10-28 |
香雪生命科学技术（广东）有限公司 |
识别ssx2抗原短肽的t细胞受体
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
MX2021001431A
(es)
|
2018-08-10 |
2021-05-12 |
Chugai Pharmaceutical Co Ltd |
Molecula de union al antigeno anti grupo de diferenciacion 137 (cd137) y su uso.
|
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
|
CN110950949B
(zh)
*
|
2018-09-26 |
2022-04-05 |
香雪生命科学技术（广东）有限公司 |
一种识别ssx2抗原的t细胞受体
|
|
AU2019365238A1
(en)
|
2018-10-24 |
2021-05-13 |
F. Hoffmann-La Roche Ag |
Conjugated chemical inducers of degradation and methods of use
|
|
EP3894427A1
(en)
|
2018-12-10 |
2021-10-20 |
Genentech, Inc. |
Photocrosslinking peptides for site specific conjugation to fc-containing proteins
|
|
TW202039535A
(zh)
|
2018-12-18 |
2020-11-01 |
德商英麥提克生物技術股份有限公司 |
B*08限制肽和肽組合物抗癌免疫治療和相關方法
|
|
KR102084912B1
(ko)
*
|
2019-01-17 |
2020-03-05 |
주식회사 녹십자 |
B형 간염 바이러스 표면 항원의 입체 에피토프 및 이에 특이적으로 결합하는 항체
|
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
|
JP7232925B2
(ja)
|
2019-02-15 |
2023-03-03 |
ウーシー バイオロジクス アイルランド リミテッド |
改善された均一性を有する抗体薬物コンジュゲートの調製するプロセス
|
|
CN113631560B
(zh)
|
2019-03-15 |
2025-02-18 |
麦迪穆有限责任公司 |
氮杂环丁烷并苯并二氮杂䓬二聚体和用于治疗癌症的包含它们的缀合物
|
|
CN112442118B
(zh)
*
|
2019-08-30 |
2023-02-14 |
深圳普瑞金生物药业股份有限公司 |
一种tcr及其应用
|
|
CH717565A1
(fr)
|
2020-06-25 |
2021-12-30 |
Planair Sa |
Installation photovoltaïque et procédé de construction d'une telle installation.
|
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|
|
US11421015B2
(en)
|
2020-12-07 |
2022-08-23 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
US11058751B1
(en)
|
2020-11-20 |
2021-07-13 |
Think Therapeutics, Inc. |
Compositions for optimized RAS peptide vaccines
|
|
US11161892B1
(en)
|
2020-12-07 |
2021-11-02 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
CN116710115A
(zh)
|
2020-11-20 |
2023-09-05 |
思维疗法股份有限公司 |
用于优化的肽疫苗的组合物和方法
|
|
US11464842B1
(en)
|
2021-04-28 |
2022-10-11 |
Think Therapeutics, Inc. |
Compositions and method for optimized peptide vaccines using residue optimization
|
|
CN117980327A
(zh)
|
2021-11-03 |
2024-05-03 |
杭州多禧生物科技有限公司 |
抗体的特异性偶联
|
|
CN116262779A
(zh)
*
|
2021-12-14 |
2023-06-16 |
深圳先进技术研究院 |
一种单细胞筛选鉴定人乳头瘤病毒特异性tcr的方法
|
|
EP4328239A1
(en)
|
2022-08-26 |
2024-02-28 |
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft |
Immunotherapeutics based on magea1-derived epitopes
|
|
CN120417934A
(zh)
|
2022-12-23 |
2025-08-01 |
基因泰克公司 |
Cereblon降解剂缀合物及其用途
|
|
KR20260012304A
(ko)
|
2023-04-17 |
2026-01-26 |
피크 바이오, 인크. |
항체 및 항체-약물 접합체 및 사용 방법 및 합성 공정 및 중간체
|
|
WO2026006688A2
(en)
|
2024-06-28 |
2026-01-02 |
Firefly Bio, Inc. |
Degrader antibody conjugates and uses thereof
|
|
TW202617186A
(zh)
|
2024-06-28 |
2026-05-01 |
美商飛爾富來生物公司 |
Ｂｃｌ－ｘｌ降解劑抗體結合物及其用途
|